West Pharmaceutical Services and HealthPrize Technologies are working to integrate Software-as-a-Service (SaaS) medication adherence and a patient-engagement platform with West’s injectable drug delivery systems
West Pharmaceutical Services and HealthPrize Technologies collaboration offers digital drug delivery system
This collaboration will provide a connected health solution for pharmaceutical companies and patients.
West Pharmaceutical Services and HealthPrize’s combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication.
The HealthPrize system engages and educates patients to increase adherence and medical understanding, rewarding interaction and compliance with prescribed treatment plans and contributing to better health outcomes.
Phase 1 of the platform allows for patient self-reporting once the medication has been injected. Phase 2 simplifies the self-reporting process through bar coding or QR coding of self-injection systems which when scanned reports use of the injection system to the HealthPrize patient-engagement system via a secure cloud environment.
Bar coding allows for the recording of other medication details including manufacturing information, pedigree, expiration date, dosage and more.
The final phases of development are currently in progress and include integrated injection systems with monitoring and built-in wireless communication capability and the connection to the HealthPrize platform via an adaptive attachment.
In all four phases, data captured over time will give pharmaceutical companies insight into trends and analytics regarding the actual use of their products.
HealthPrize CEO and co-founder, Tom Kottler, said: “Our collaboration with West represents a significant leap forward in the ability to engage patients in a meaningful way regarding their injectable treatments, not only in motivating patients to stick with therapy, allowing for improved outcomes, but also in providing pharmaceutical clients with accurate and actionable real-time use data.”